Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors

Published:2024-08 Issue:8 Volume:22 Page:2211-2226
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Schreuder Mark,Jourdi Georges,Veizaj Dejvid,Poole David A.,Cheung Ka Lei,Poenou Géraldine,Verhoef Daniël,Thomassen Stella,Janssen Laura F.H.,Stepanian Alain,Hackeng Tilman M.,Gaussem Pascale,Reitsma Pieter H.,Geerke Daan P.,Siguret Virginie,Bos Mettine H.A.

Funder

Landsteiner Foundation for Blood Transfusion Research

Publisher

Elsevier BV

Reference78 articles.

1. Global burden of thrombosis: epidemiologic aspects;Wendelboe;Circ Res,2016

2. Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor;Roehrig;J Med Chem,2005

3. Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro- 1H-pyrazolo[3,4-c]pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa

4. DU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles;Furugohri;J Thromb Haemost,2008

5. Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenz amide, a highly potent, selective, and orally efficacious factor Xa inhibitor;Zhang;Bioorg Med Chem Lett,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP